Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia.
about
The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationEarly adenosine receptor activation ameliorates spinal cord reperfusion injury.A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists.Change in platelet endothelial cell adhesion molecule-1 immunoreactivity in the dentate gyrus in gerbils fed a folate-deficient dietDevelopment and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury.Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury.Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeAdenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.Effect of adenosine A2A receptor activation in murine models of respiratory disorders.Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model.Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury.
P2860
Q30409961-07655758-7208-473A-B006-5004F3ADD41EQ30439172-BADDBC0F-377C-4810-8EAA-14E28231CEB0Q30440793-C749920E-CF37-4DD3-9EF3-D61EDE579705Q35064892-7FCB5941-96B0-4677-8BFF-AC30E8D6ADF0Q36782030-E3270723-5B92-4FA8-BE4B-428C349E044FQ37057821-631523AA-2E6E-44CE-8391-F36F4BF7038EQ37863150-43549827-AD3D-4725-9DB7-9760A33E23A4Q40722338-DC78FB91-A5F9-4BD3-B8A1-B833196C7428Q42594826-A5A48A18-7A59-4256-921D-9448F60F6B00Q46844203-A0B07C79-5B1B-4D8E-B2C7-F36AED82F04CQ48491942-44C61E5C-C1C0-41D8-A6CB-CB5B5A105AFBQ53600926-A9FD6B2F-F077-4419-B131-6A7C23CDB494Q55262715-9D14778F-96AE-45FB-A7E7-B8C9E7AADE96
P2860
Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@ast
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@en
type
label
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@ast
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@en
prefLabel
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@ast
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@en
P2093
P50
P356
P1476
Adenosine A2A analogue ATL-146 ...... on after spinal cord ischemia.
@en
P2093
Aditya K Kaza
Bao-Ngoc Nguyen
David C Cassada
Jayson M Rieger
Joel Linden
John A Kern
Steven M Fiser
Stewart M Long
P304
P356
10.1067/MVA.2002.123091
P577
2002-05-01T00:00:00Z